Your browser doesn't support javascript.
loading
Concomitant Drugs Prognostic Score in Patients With Metastatic Renal Cell Carcinoma Receiving Ipilimumab and Nivolumab in the Compassionate Use Program in Italy: Brief Communication.
Buti, Sebastiano; Basso, Umberto; Giannarelli, Diana; De Giorgi, Ugo; Maruzzo, Marco; Iacovelli, Roberto; Galli, Luca; Porta, Camillo; Carrozza, Francesco; Procopio, Giuseppe; Fonarini, Giuseppe; Lo Re, Giovanni; Santoni, Matteo; Sabbatini, Roberto; Cusmai, Antonio; Zucali, Paolo Andrea; Aschele, Carlo; Baldini, Editta; Zafarana, Elena; Favaretto, Adolfo; Leo, Silvana; Hamzaj, Alketa; Mirabelli, Rosanna; Nole', Franco; Zai, Silvia; Chini, Claudio; Masini, Cristina; Fatigoni, Sonia; Rocchi, Andrea; Tamburini, Emiliano; Cortellini, Alessio; Bersanelli, Melissa.
Afiliación
  • Buti S; Department of Medicine and Surgery, University of Parma, Parma.
  • Basso U; Medical Oncology Unit, University Hospital of Parma, Parma.
  • Giannarelli D; Oncology Unit 1, Department of Oncology, Istituto Oncologico Veneto IOV - IRCCS, Padua.
  • De Giorgi U; Department of Biostatistical, Regina Elena National Cancer Institute, IRCCS, Rome.
  • Maruzzo M; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola.
  • Iacovelli R; Oncology Unit 1, Department of Oncology, Istituto Oncologico Veneto IOV - IRCCS, Padua.
  • Galli L; Department of Medical and Surgical Sciences, Medical Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma.
  • Porta C; Unit of Medical Oncology 2, Department of Translational Research and New Technologies in Medicine and Surgery, Azienda Ospedaliera Universitaria Pisana, Pisa.
  • Carrozza F; Department of Biomedical Sciences and Human Oncology, University of Bari 'A. Moro' and Division of Medical Oncology, A.O.U. Consorziale Policlinico di Bari.
  • Procopio G; Oncology Unit" Santa Maria delle Croci Hospital", Department Oncology and Haematology AUSL, Romagna, Ravenna.
  • Fonarini G; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori.
  • Lo Re G; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova.
  • Santoni M; Division of Medical Oncology and Immune-Related Tumors, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano.
  • Sabbatini R; Medical Oncology Unit, Hospital of Macerata, Macerata.
  • Cusmai A; Oncological Medicine Unit and Medical Oncology Unit, Department of Oncology and Haematology, University Hospital of Modena, University of Modena and Reggio Emilia, Modena.
  • Zucali PA; Interventional and Medical Oncology Unit, National Cancer Research Center, Istituto Tumori Giovanni Paolo II, Viale Orazio Flacco, Bari.
  • Aschele C; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele.
  • Baldini E; Department of Oncology, IRCCS Humanitas Research Hospital, Rozzano.
  • Zafarana E; Department of Oncology, Ospedale S. Andrea, La Spezia.
  • Favaretto A; Department of Medical Oncology, San Luca Hospital, Lucca.
  • Leo S; Department of Medical Oncology, Hospital of Prato, Prato.
  • Hamzaj A; Department of Medical Oncology, AULSS 2 Marca Trevigiana, Ca'Foncello Hospital, Treviso.
  • Mirabelli R; Medical Oncology Unit, Vito Fazzi Hospital, Lecce.
  • Nole' F; UOC Oncologia Arezzo, Ospedale San Donato, Arezzo.
  • Zai S; Department of Ematology and Oncology, Pugliese-Ciaccio Hospital, Catanzaro.
  • Chini C; Medical Oncology Division of Urogenital and Head and Neck Tumours IEO, European Institute of Oncology IRCCS, Milan.
  • Masini C; Medical Oncology Unit, Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo, Alessandria.
  • Fatigoni S; Department of Medical Oncology, ASST Sette Laghi, Ospedale di Circolo e Fondazione Macchi, Varese.
  • Rocchi A; Medical Oncology Unit, Clinical Cancer Centre, AUSL-IRCCS di Reggio Emilia, Reggio Emilia.
  • Tamburini E; Medical Oncology, Santa Maria della Misericordia Hospital, University of Perugia, Perugia.
  • Cortellini A; Hematology and Oncology Unit, San Giovanni Battista Hospital, Foligno.
  • Bersanelli M; Department of Oncology and Palliative Care, Cardinale G. Panico, Tricase City Hospital, Tricase, Italy.
J Immunother ; 46(1): 22-26, 2023 01 01.
Article en En | MEDLINE | ID: mdl-36472582
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos